June 16

PBS support for Australians living with leukaemia

first_imgPBS support for Australians living with leukaemia Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded access to a breakthrough medicine through the Pharmaceutical Benefits Scheme (PBS).From 1 December, access to Venclexta® (venetoclax) will be extended in combination with obinutuzumab for the first-line treatment of patients with chronic lymphocytic leukaemia who have co-existing conditions and are unsuitable for fludarabine-based chemo-immunotherapy.Chronic lymphocytic leukaemia is a relatively uncommon type of cancer however it is the most common type of leukaemia diagnosed in Australia with around 1,000 people diagnosed each year.Based on a landmark research discovery by the Walter and Eliza Hall Institute of Medical Research, Venclexta was also co-developed and trialled in Australia, showcasing the great work of our nation’s medical researchers.Up to 500 patients every year are expected to benefit from this listing.Without PBS subsidy, these patients would pay more than $69,250 per course of treatment. Thanks to PBS subsidy, they will pay $41 per script or $6.60 with a concession card.The Morrison Government is continuing to make important medicines available to Australians at affordable prices.These PBS listings have been recommended by the independent Pharmaceutical Benefits Advisory Committee.Since 2013, the Government has approved more than 2,500 new or amended listings on the PBS at an overall investment by the Government of over $11.8 billion.The Government’s commitment to ensuring that Australians can access affordable medicines, when they need them, remains rock solid. /Media Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:AusPol, Australia, breakthrough, cancer, chronic, Department of Health, Discovery, Government, health, healthcare, Investment, leukaemia, Medical research, medicine, Morrison, Morrison Government, research, treatment, Walter and Eliza Hall Institutelast_img

Tags: , , , , , , , , , , ,
Copyright 2021. All rights reserved.

Posted June 16, 2021 by admin in category "jbriezpdm

Leave a Reply

Your email address will not be published. Required fields are marked *